Found 7 matching trials
Post-Market Study to Assess iTind Safety in Comparison to UroLift
NAThe study objective is to evaluate the efficacy and safety of the iTind dev...
Location
Mayo Clinic Arizona
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
NAThe study objectives are to demonstrate the efficacy and safety of the Medi...
Location
Clinical Research Center of Florida
Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH
NAA total of up to 200 Symptomatic BPH subjects subjects will be enrolled int...
Location
Sydney Adventist Hospital Clinical School of the University of Sydney
A Prospective Study to Observe the Mechanism of Action of the MediTate iTind in Subjects With Symptomatic BPH With MRI
NAA total of up to 15 eligible subjects will be enrolled into this open-label...
Location
Kliniken Nordoberpfalz AG Klinik für Urologie, Kinderurologie und interdisziplinäres Prostatakarzinomzentrum
Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH
NAThis is a prospective series of consecutive cases of patients undergoing iT...
Location
Prince of Wales Hospital
Study to Assess the Efficacy, Safety and Tolerability of (iTind)
NASubjects with AUR secondary to BPO that comply with Inclusion/Exclusion Cri...
Location
Firmly Park Hospital
Study to Assess the Efficacy of Medi-Tate iTind Device
NAThe study will include an implantation of the iTind device and 4 follow up ...